DIRK M. VAN OS
Irvine,CA
Summary
Award winning strategic Rare Disease Account Manager with specialty pharmaceutical and biologic experience spanning complex/rare disease. Consistent Top 10% ranking throughout my career. Successful sales growth in every territory managed. Launched several products and indications across various disease states collaborating with internal and external stakeholders to maximize a patient centric sales approach.
Overview
19
19
years of professional experience
Work History
Senior Rare Disease Account Manager
Calliditas Therapeutics
06.2025 - Current
- 1 of only 3 Rare Disease Account Managers promoted to Senior status nationally.
- Consistently mentor colleagues regionally and nationally to achieve team objectives.
- Consult with clinicians to better identify appropriate patients resulting in quarterly sales growth.
- Work closely with training and marketing departments to generate new concepts to advance sales and training.
- Consistently achieve or exceed company-defined sales goals.
- Call Points: Nephrology, Internal Medicine, Mid-Levels
- Institutions: USC, UCI
- Product/Disease State: Tarpeyo (IgA Nephropathy)
Rare Disease Account Manager
Calliditas Therapeutics
01.2023 - 05.2025
- Promote 1st and Only Disease Specific medication approved by the FDA for IgA Nephropathy to Nephrologists throughout the Greater Los Angeles Area.
- Strategically leveraged my selling skills with rapport building, resulting in a successful launch to date.
- National Field Sales Trainer.
- Exceeded all corporate driven sales goals YTD.
- Currently, ranked in top 30% of sales force (22/70) with 60+ new enrollments in 2024.
- Consistent and successful HUB distribution pull-through.
- Call Points: Nephrology, Internal Medicine, Mid-Levels
- Institutions: USC, UCI
- Product/Disease State: Tarpeyo (IgA Nephropathy)
Rare Disease Account Manager
Eversana
01.2022 - 01.2023
- Promote 1st and Only Disease Specific medication approved by the FDA for IgA Nephropathy to Nephrologists throughout the Greater Los Angeles Area.
- Strategically leveraged my selling skills with rapport building, resulting in a successful launch to date.
- Successfully completed training on Mechanism of Disease, Mechanism of Action for new treatment; all while fully onboarding with a new company.
- Exceeded all corporate driven sales goals YTD.
- Currently, ranked in top 10% of sales force (5/37) with 60+ new enrollments YTD.
- Inaugural Launch Year President's Club Award Winner.
- Call Points: Nephrology, Internal Medicine, Mid-Levels
- Institutions: USC, UCLA, Cedars Sinai, UCI
- Product/Disease State: Tarpeyo (IgA Nephropathy)
Renal Sales Specialist
AstraZeneca, LLC
11.2020 - 01.2022
- Promoted renal portfolio to Hospitals, Academic Institutions, Dialysis Centers and targeted physicians.
- Strategically leveraged cross-functional partnerships in commercial and market access in a successful launch of 2 products.
- Exceeded sales goals quarter over quarter 2021 resulting in consistently high rankings.
- Gained formulary approval at several accounts: Loma Linda UMC, Arrowhead RMC, Eisenhower, San Gorgonio, Redlands Community Hospital, Community Hospital of San Bernardino and Desert Valley.
- Implemented Guidelines for product access at specialty pharmacies rolled out regionally to >60 representatives.
- Nominated by senior management to participate in 'LEAP' a leadership development course at AstraZeneca designated for top performers.
- Call Points: Nephrology, Emergency Medicine, Internal Medicine, Hospitalists, Academic Institutions, Dialysis Centers
- Institutions: Loma Linda University Medical Center, Arrowhead Regional Medical Center, Redlands Community Hospital, St. Bernardine's, St. Mary's, Eisenhower Medical Center, Desert Healthcare, Riverside University Healthcare
- Products/Disease States: LOKELMA (Hyperkalemia), FARXIGA (CKD Progression)
Critical Care Specialist
La Jolla Pharmaceutical, Inc.
10.2019 - 11.2020
- Promoted Critical Care/Infectious Disease portfolios to Hospitals, Academic Institutions, In-Patient Pharmacies and targeted physicians.
- Strategically leveraged cross-functional partnerships in market access and reimbursement in a successful launch of 2 products.
- Exceeded target sales goals for both products resulting in a consistent Top 3 ranking among peers.
- Grew Physician/Staff comfort level for both products in targeted hospitals via a consultative sales approach to identify appropriate patients resulting in 155% sales growth in 2020.
- Appointed to several Regional/National advisory teams to increase best practices with colleagues.
- Call Points: Critical Care, Pulmonology, Thoracic Surgeons, Hospitalists, Infectious Disease, Pharmacy
- Institutions: Sharp Health System, Scripps Health System, UCSD, UCI, Hoag, Memorial Care, Providence/St. Joseph Health, Hawaii Pacific Health, Queens Hospital.
- Products/Disease States: GIAPREZA (Septic Shock), XERAVA (Complicated Intra-Abdominal Infections)
Account Manager
Otsuka America Pharmaceutical, Inc.
04.2011 - 10.2019
- Promoted Renal/CNS portfolios to Hospitals, Academic Institutions, Clinics, Specialty Pharmacies and targeted physicians.
- Strategically leveraged cross-functional partnerships in commercial access and reimbursement in a successful launch of promoted products.
- Delivered >100% YOY business growth during tenure resulting in consistently high rankings.
- Increased product utilization by developing a continuum of care to appropriately treat patients.
- 2015 President's Club Award Winner.
- Selected by management to work several national/regional conventions/congresses.
- Call Points: Nephrology, Cardiology, Hospitalists, Psychiatry, Emergency Medicine, HUB Pharmacy
- Institutions: Loma Linda UMC, Redlands Community, St, Bernardines, Riverside Community, Parkview Community, Temecula Valley, Eisenhower MC, Desert Regional MC, Arrowhead Regional, Corona Regional, Southwest Healthcare
- Products/Disease States: SAMSCA (Hyponatremia), JYNARQUE (Polycystic Kidney Disease: rare disease), Abilify Maintena (once-monthly injectable antipsychotic)
Hospital Sales Representative
Merck & Co., Inc.
06.2006 - 04.2011
- Promoted Infectious Disease portfolio and leading Glycoprotein IIb/IIIa Inhibitor to Hospitals, Academic Institutions, Specialty Pharmacies and targeted specialty clinics.
- Strategically leveraged cross-functional partnerships in commercial access and reimbursement in successful sales growth of 2 products.
- Managed $1.6MM territory with consistent YOY business growth during tenure.
- Increased product utilization by developing a continuum of care to appropriately treat patients.
- 2010 President's Club Award.
- Selected by management to work several national/regional conventions.
- Call Points: Interventional Cardiology, Hospitalists, Infectious Disease, In-Patient Pharmacy
- Institutions: Loma Linda UMC, St. Mary's MC, St, Bernardines, Riverside Community, Parkview Community, Temecula Valley, Eisenhower MC, Desert Regional MC, Arrowhead Regional, Corona Regional, Southwest Healthcare
- Products/Disease States: INTEGRILIN (Acute Coronary Syndrome), AVELOX/CIPRO (Antibiotics)
Education
Bachelor of Arts -
California State University, Fullerton
Fullerton, CA06.1994
Skills
Areas of Expertise:
- Injectable/infused products
- Buy & Bill/ Specialty Pharmacy
- KOL Development
- Cardio-Renal/Pulmonary/Critical Care
- HUB-Prescription Pull Through
Timeline
Senior Rare Disease Account Manager
Calliditas Therapeutics
06.2025 - Current
Rare Disease Account Manager
Calliditas Therapeutics
01.2023 - 05.2025
Rare Disease Account Manager
Eversana
01.2022 - 01.2023
Renal Sales Specialist
AstraZeneca, LLC
11.2020 - 01.2022
Critical Care Specialist
La Jolla Pharmaceutical, Inc.
10.2019 - 11.2020
Account Manager
Otsuka America Pharmaceutical, Inc.
04.2011 - 10.2019
Hospital Sales Representative
Merck & Co., Inc.
06.2006 - 04.2011
Bachelor of Arts -
California State University, Fullerton
Similar Profiles
David L. FerraroDavid L. Ferraro
Vice President of Sales at Calliditas TherapeuticsVice President of Sales at Calliditas Therapeutics
Anthony J. Varano, Jr.Anthony J. Varano, Jr.
Co-Founder, CEO & Investor at Cervello Therapeutics & Resero TherapeuticsCo-Founder, CEO & Investor at Cervello Therapeutics & Resero Therapeutics
Niharika ObristNiharika Obrist
Project Manager at NovaGo Therapeutics AGProject Manager at NovaGo Therapeutics AG
Brookelynn KleinBrookelynn Klein
Multi-Line Insurance Agent at AflacMulti-Line Insurance Agent at Aflac
Agostino MilazzoAgostino Milazzo
Owner at ClientsIOOwner at ClientsIO